Compare VAC & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VAC | ATRC |
|---|---|---|
| Founded | 1984 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.6B |
| IPO Year | N/A | 2005 |
| Metric | VAC | ATRC |
|---|---|---|
| Price | $57.49 | $39.63 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 8 | 9 |
| Target Price | ★ $64.00 | $52.22 |
| AVG Volume (30 Days) | ★ 820.9K | 488.6K |
| Earning Date | 11-05-2025 | 02-11-2026 |
| Dividend Yield | ★ 5.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.58 | N/A |
| Revenue | ★ $3,358,000,000.00 | $518,304,999.00 |
| Revenue This Year | $54.51 | $16.90 |
| Revenue Next Year | $2.59 | $12.25 |
| P/E Ratio | $12.76 | ★ N/A |
| Revenue Growth | 5.13 | ★ 15.80 |
| 52 Week Low | $44.58 | $28.29 |
| 52 Week High | $91.18 | $43.11 |
| Indicator | VAC | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 52.68 | 52.77 |
| Support Level | $57.53 | $40.11 |
| Resistance Level | $58.71 | $41.33 |
| Average True Range (ATR) | 1.66 | 1.11 |
| MACD | 0.19 | -0.31 |
| Stochastic Oscillator | 58.66 | 2.63 |
Marriott Vacations Worldwide Corp functions in the United States leisure industry. It owns and manages a cluster of resorts and accommodation facilities under trademarks like Marriott Vacation Club, Grand Residencies, and The Ritz-Carlton Destination Club predominantly in the United States. Some of its properties are also spread across Europe and Asia Pacific. Marriott's majority revenue components include the sale of vacation ownership products such as luxurious vacation packages. In addition, it offers purchase money financing to the end users of its core services. The company operates in two reportable segments: Vacation Ownership and Exchange & Third-Party Management. The majority of revenue is derived from the Vacation Ownership segment.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.